Network Immunology Inc. is a privately held biotechnology company developing novel immuno-therapies based on immune network theory.
CEO George Hoffman discusses Network Immunology's latest research breakthrough in organ transplantation. ..
Toronto, ON: Network Immunology has received breakthrough data for its platform Co-selection Technology™ that has potential applications to transplantation, autoimmunity and other degenerati..
Vancouver, BC: Network Immunology has completed a financing in partnership with one of the largest wealth management firms in Canada. “We are delighted with this development, as it is a majo..